As the European markets navigate through heightened geopolitical tensions and fluctuating energy prices, investor focus has shifted towards corporate fundamentals amidst the ongoing earnings season. In this landscape, growth companies with high insider ownership are drawing attention for their potential resilience and alignment of interests between management and shareholders.
| Name | Insider Ownership | Earnings Growth |
| Pharma Mar (BME:PHM) | 12.1% | 39.9% |
| OSE Immunotherapeutics (ENXTPA:OSE) | 23% | 73.3% |
| Kuros Biosciences (SWX:KURN) | 23.7% | 65.6% |
| KebNi (OM:KEBNI B) | 16.3% | 111.0% |
| Gold Road International (OB:GOLDR) | 36.7% | 89.8% |
| CTT Systems (OM:CTT) | 17.4% | 55.3% |
| Clavister Holding AB (publ.) (OM:CLAV) | 19.4% | 41.1% |
| Bonesupport Holding (OM:BONEX) | 10.6% | 32.4% |
| Bergen Carbon Solutions (OB:BCS) | 11.9% | 52% |
| 2G Energy (XTRA:2GB) | 13.4% | 35.6% |
Let's take a closer look at a couple of our picks from the screened companies.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Basic-Fit N.V. operates and franchises fitness clubs across multiple European countries under the Basic-Fit brand, with a market cap of €1.94 billion.
Operations: The company generates revenue from its fitness clubs in the Benelux region with €581.70 million and from France, Spain, and Germany with €920.20 million.
Insider Ownership: 12%
Basic-Fit has demonstrated a strong turnaround, reporting EUR 23.1 million net income for H1 2026 compared to a loss last year. Earnings are forecast to grow significantly at 32.4% annually, outpacing the Dutch market. However, revenue growth is expected to lag behind the market at 9.4% per year. The stock trades at 38.7% below its estimated fair value, with analysts predicting a potential price increase of 41.5%. No substantial insider trading activity in recent months was noted.
Simply Wall St Growth Rating: ★★★★★★
Overview: Bonesupport Holding AB is an orthobiologics company that develops and commercializes injectable bio-ceramic bone graft substitutes globally, with a market cap of SEK16.84 billion.
Operations: The company generates revenue primarily from its Pharmaceuticals segment, which amounted to SEK1.29 billion.
Insider Ownership: 10.6%
Bonesupport Holding's earnings are projected to grow significantly at 32.4% annually, surpassing the Swedish market's growth rate. Revenue is expected to increase by 22.3% per year, outpacing the broader market as well. The stock trades at a significant discount of 42.8% below its estimated fair value, with analysts anticipating a potential price rise of 39%. Recent insider activity shows more shares bought than sold, although not in substantial volumes.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Humble Group AB (publ) is involved in the development, production, and distribution of fast-moving consumer goods both in Sweden and internationally, with a market cap of approximately SEK2.72 billion.
Operations: Humble Group AB (publ) generates revenue through its development, production, and distribution of fast-moving consumer goods across Sweden and international markets.
Insider Ownership: 24%
Humble Group is experiencing robust growth, with third-quarter sales rising to SEK 2.20 billion and a return to profitability, reporting a net income of SEK 66 million. The company forecasts revenue growth of 6.8% annually, outpacing the Swedish market's decline. Despite trading at an estimated 80.9% below fair value, Humble is expected to achieve above-average market profit growth in three years. Recent executive changes aim to enhance leadership and drive profitability improvements across its segments.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com